AGENT FOR CORRECTING METABOLIC SYNDROME

The invention relates to medicine and, more particularly, to agents for correcting metabolic syndrome. The proposed agent for correcting metabolic syndrome is in the form of the tripeptide L-lysyl-L-glutamyl-L-tryptophan of general formula (I), where X=OH or NH2. L'invention concerne la médecin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	MALININ, VLADIMIR VIKTOROVICH
Format:	Patent
Sprache:	eng ; fre ; rus
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to medicine and, more particularly, to agents for correcting metabolic syndrome. The proposed agent for correcting metabolic syndrome is in the form of the tripeptide L-lysyl-L-glutamyl-L-tryptophan of general formula (I), where X=OH or NH2. L'invention concerne la médecine et notamment des produits de correction du syndrome métabolique. On utilise en tant que produit de correction du syndrome métabolique le tripeptide L-lysine-L-glutamyl-L-tryptophane correspondant à la formule générale (I) dans laquelle = ou NH2.